Jessica Lee Mueller, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hirschsprung Disease | 2 | 2022 | 143 | 1.030 |
Why?
|
| Enteric Nervous System | 2 | 2022 | 160 | 0.960 |
Why?
|
| Hypophosphatemia | 1 | 2018 | 93 | 0.670 |
Why?
|
| Pancreatic Fistula | 1 | 2018 | 146 | 0.660 |
Why?
|
| Hepatectomy | 1 | 2021 | 561 | 0.640 |
Why?
|
| Phosphates | 1 | 2018 | 787 | 0.560 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2018 | 509 | 0.540 |
Why?
|
| Gastrectomy | 1 | 2018 | 538 | 0.520 |
Why?
|
| Lipase | 1 | 2016 | 313 | 0.510 |
Why?
|
| Pancreatectomy | 1 | 2018 | 845 | 0.490 |
Why?
|
| Epidermal Growth Factor | 1 | 2016 | 724 | 0.470 |
Why?
|
| Emigrants and Immigrants | 1 | 2018 | 475 | 0.460 |
Why?
|
| Lymph Node Excision | 1 | 2018 | 1179 | 0.450 |
Why?
|
| Interleukins | 1 | 2016 | 799 | 0.420 |
Why?
|
| Stomach Neoplasms | 1 | 2018 | 1214 | 0.370 |
Why?
|
| Liver Transplantation | 2 | 2016 | 2022 | 0.350 |
Why?
|
| Hepatitis C, Chronic | 1 | 2016 | 1002 | 0.330 |
Why?
|
| Liver Cirrhosis | 2 | 2016 | 1721 | 0.300 |
Why?
|
| Risk Adjustment | 2 | 2017 | 587 | 0.230 |
Why?
|
| Enterocolitis | 1 | 2022 | 92 | 0.220 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 6338 | 0.200 |
Why?
|
| Benchmarking | 2 | 2017 | 915 | 0.200 |
Why?
|
| Neural Crest | 1 | 2022 | 266 | 0.200 |
Why?
|
| Membrane Proteins | 1 | 2016 | 8072 | 0.170 |
Why?
|
| Postoperative Complications | 2 | 2021 | 15053 | 0.160 |
Why?
|
| Republic of Korea | 1 | 2018 | 568 | 0.150 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 15485 | 0.150 |
Why?
|
| Neurogenesis | 1 | 2022 | 833 | 0.140 |
Why?
|
| Paracentesis | 1 | 2015 | 94 | 0.130 |
Why?
|
| Apolipoproteins | 1 | 2016 | 303 | 0.130 |
Why?
|
| Surgical Procedures, Operative | 2 | 2017 | 1880 | 0.130 |
Why?
|
| Specialties, Surgical | 1 | 2019 | 387 | 0.130 |
Why?
|
| Chi-Square Distribution | 1 | 2021 | 3562 | 0.130 |
Why?
|
| SEER Program | 1 | 2018 | 1549 | 0.120 |
Why?
|
| Stem Cell Transplantation | 1 | 2022 | 1660 | 0.120 |
Why?
|
| Interferons | 1 | 2016 | 667 | 0.110 |
Why?
|
| Albumins | 1 | 2015 | 563 | 0.110 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 649 | 0.110 |
Why?
|
| Data Interpretation, Statistical | 2 | 2019 | 2716 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2018 | 3093 | 0.100 |
Why?
|
| Hepacivirus | 1 | 2016 | 1309 | 0.090 |
Why?
|
| Massachusetts | 1 | 2021 | 8712 | 0.080 |
Why?
|
| Time Factors | 2 | 2021 | 41038 | 0.080 |
Why?
|
| Transplantation, Homologous | 1 | 2016 | 4831 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2021 | 12447 | 0.080 |
Why?
|
| General Surgery | 1 | 2018 | 1645 | 0.080 |
Why?
|
| Tissue Donors | 1 | 2016 | 2147 | 0.070 |
Why?
|
| Prognosis | 2 | 2018 | 28919 | 0.070 |
Why?
|
| Graft Survival | 1 | 2016 | 3767 | 0.070 |
Why?
|
| Genotype | 2 | 2016 | 12863 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 2060 | 0.060 |
Why?
|
| Antiviral Agents | 1 | 2016 | 2768 | 0.060 |
Why?
|
| Survival Rate | 1 | 2018 | 13202 | 0.060 |
Why?
|
| Age Factors | 1 | 2021 | 18712 | 0.060 |
Why?
|
| Research Design | 1 | 2019 | 5833 | 0.060 |
Why?
|
| Registries | 1 | 2018 | 7989 | 0.060 |
Why?
|
| Graft Rejection | 1 | 2016 | 4408 | 0.060 |
Why?
|
| Humans | 12 | 2022 | 708843 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 9488 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2018 | 3266 | 0.060 |
Why?
|
| Risk Factors | 3 | 2018 | 69553 | 0.060 |
Why?
|
| Male | 6 | 2021 | 349524 | 0.050 |
Why?
|
| Middle Aged | 5 | 2018 | 213752 | 0.050 |
Why?
|
| Female | 6 | 2021 | 375205 | 0.050 |
Why?
|
| Liver | 1 | 2016 | 7622 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 4044 | 0.050 |
Why?
|
| Technology | 1 | 2022 | 237 | 0.050 |
Why?
|
| Disease Progression | 1 | 2016 | 13298 | 0.040 |
Why?
|
| Aged | 4 | 2018 | 161488 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 58184 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2018 | 23284 | 0.040 |
Why?
|
| Feces | 1 | 2022 | 1365 | 0.040 |
Why?
|
| Sample Size | 1 | 2019 | 821 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2018 | 61932 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 39038 | 0.030 |
Why?
|
| United States | 2 | 2018 | 67165 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2016 | 39292 | 0.030 |
Why?
|
| Ascites | 1 | 2015 | 343 | 0.030 |
Why?
|
| Animals | 2 | 2022 | 170486 | 0.030 |
Why?
|
| Young Adult | 2 | 2017 | 55940 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 2017 | 1156 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2018 | 71483 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2022 | 7994 | 0.020 |
Why?
|
| Proteomics | 1 | 2022 | 3244 | 0.020 |
Why?
|
| Vascular Surgical Procedures | 1 | 2017 | 1510 | 0.020 |
Why?
|
| Adult | 3 | 2017 | 211041 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2016 | 1822 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2022 | 11718 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2016 | 5095 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 11239 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2015 | 7487 | 0.010 |
Why?
|
| Mice | 1 | 2022 | 80876 | 0.010 |
Why?
|
| Child | 1 | 2022 | 73636 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2017 | 50597 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 84718 | 0.010 |
Why?
|